Immunopathological basis of PTSD

PTSD的免疫病理学基础

基本信息

项目摘要

DESCRIPTION (provided by applicant): Post-traumatic stress disorder (PTSD) is a psychiatric condition with severe symptoms associated with biological dysregulation that can occur after exposure to shock. Exposure to trauma results in modulation in the hypothalamic-pituitary-adrenal (HPA) axis, which plays a critical role in the stress response that in turn interacts reciprocally with the immune system to maintain homeostasis. To date, over 1.6 million US men and women have served in the wars in Iraq (Operation Iraqi Freedom, OIF) and Afghanistan and surrounding regions (Operation Enduring Freedom, OEF). Over 35% of returned Iraq and Afghanistan veterans in Department of Veterans Affairs (VA) care have received mental health diagnoses, the most prevalent being PTSD. Inasmuch as, there is significant prevalence of PTSD in combat veterans who have served in the Iraq and Afghanistan wars, our studies have focused on addressing the pathological basis of immune dysfunction in these men and women. In the current study, we will test the central hypothesis that PTSD associates, at least in part, with dysregulation in the epigenetic mechanisms that control the differentiation of Th1/Th2/Th17/Treg cells of the adaptive immune response, thereby altering the cytokine profiles and promoting inflammatory response. The specific aims are 1) to corroborate the serum cytokine profile with severity of PTSD and to determine the role of transcription factors that regulate the differentiation of Th/T reg cells. Furthermore, whether the cytokine expression in Th/Tregs is dependent on the mitogen activated protein kinase signaling pathway will be elucidated. 2) to address whether epigenetic mechanisms play a role in Th/Treg polarization by performing high-throughput microRNAs arrays and to determine the level of hypo- or hypermethylation of Th1, Th2, Th17 and Treg cytokine/transcription factor gene promoters. The miRNA data generated will be used in silico algorithms for related target gene prediction and pathways that are dysregulated. Further studies will be performed to assess whether reversal of the cytokine expression occurs in the T cells following transfection with miRNA mimics or antagomirs of miRNAs that are downregulated or upregulated respectively. Based on the methylation data, demethylation will be attempted using inhibitors for hypermethylated gene promoters of cytokines or their transcription factors to determine whether this would lead to reversal of the Th/Treg phenotypic characteristics. Together, these studies are novel in that they will not only help understand stress-induced alterations in immune profiles in PTSD patients but will also provide useful clues on whether epigenetic markers and specific cytokines/chemokines can serve as bio-markers of PTSD.
描述(由申请人提供):创伤后应激障碍(PTSD)是一种精神疾病,具有与生物失调相关的严重症状,可能在受到休克后发生。遭受创伤会导致下丘脑-垂体-肾上腺(HPA)轴的调节,这在应激反应中发挥着关键作用,而应激反应又与免疫系统相互作用以维持体内平衡。迄今为止,已有超过 160 万美国军人参加了伊拉克战争(伊拉克自由行动,OIF)和阿富汗及周边地区战争(持久自由行动,OEF)。在退伍军人事务部 (VA) 护理中,超过 35% 的返回伊拉克和阿富汗退伍军人接受过心理健康诊断,其中最常见的是创伤后应激障碍 (PTSD)。由于在伊拉克和阿富汗战争中服役的退伍军人中创伤后应激障碍(PTSD)的患病率很高,因此我们的研究重点是解决这些男女免疫功能障碍的病理基础。在当前的研究中,我们将检验一个中心假设,即 PTSD 至少部分与控制适应性免疫反应的 Th1/Th2/Th17/Treg 细胞分化的表观遗传机制失调相关,从而改变细胞因子谱并促进炎症反应。具体目标是 1) 证实血清细胞因子谱与 PTSD 严重程度的关系,并确定调节 Th/T reg 细胞分化的转录因子的作用。此外,将阐明 Th/Treg 中的细胞因子表达是否依赖于丝裂原激活的蛋白激酶信号通路。 2) 通过执行高通量 microRNA 阵列来确定表观遗传机制是否在 Th/Treg 极化中发挥作用,并确定 Th1、Th2、Th17 和 Treg 细胞因子/转录因子基因启动子的低甲基化或高甲基化水平。生成的 miRNA 数据将用于计算机算法中,用于相关靶基因预测和失调通路。将进行进一步的研究来评估转染分别下调或上调的 miRNA 的 miRNA 模拟物或 antagomir 后 T 细胞中是否会发生细胞因子表达的逆转。根据甲基化数据,将尝试使用细胞因子或其转录因子的高甲基化基因启动子抑制剂进行去甲基化,以确定这是否会导致 Th/Treg 表型特征的逆转。总之,这些研究的新颖之处在于,它们不仅有助于了解应激引起的 PTSD 患者免疫特征的改变,而且还将为表观遗传标记和特定细胞因子/趋化因子是否可以作为 PTSD 的生物标记提供有用的线索。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Prakash S Nagarkatti其他文献

Prakash S Nagarkatti的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Prakash S Nagarkatti', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10428525
  • 财政年份:
    2012
  • 资助金额:
    $ 34.52万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10227907
  • 财政年份:
    2012
  • 资助金额:
    $ 34.52万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10830736
  • 财政年份:
    2012
  • 资助金额:
    $ 34.52万
  • 项目类别:
Center for Dietary Supplements and Inflammation
膳食补充剂和炎症中心
  • 批准号:
    8531296
  • 财政年份:
    2012
  • 资助金额:
    $ 34.52万
  • 项目类别:
Center for Dietary Supplements and Inflammation
膳食补充剂和炎症中心
  • 批准号:
    8733726
  • 财政年份:
    2012
  • 资助金额:
    $ 34.52万
  • 项目类别:
Center for Dietary Supplements and Inflammation
膳食补充剂和炎症中心
  • 批准号:
    8216765
  • 财政年份:
    2012
  • 资助金额:
    $ 34.52万
  • 项目类别:
Immunopathological basis of PTSD
PTSD的免疫病理学基础
  • 批准号:
    8466380
  • 财政年份:
    2011
  • 资助金额:
    $ 34.52万
  • 项目类别:
Immunopathological basis of PTSD
PTSD的免疫病理学基础
  • 批准号:
    8167365
  • 财政年份:
    2011
  • 资助金额:
    $ 34.52万
  • 项目类别:
Immunopathological basis of PTSD
PTSD的免疫病理学基础
  • 批准号:
    8662798
  • 财政年份:
    2011
  • 资助金额:
    $ 34.52万
  • 项目类别:
Use of Resveratrol to treat experimental multiple sclerosis
使用白藜芦醇治疗实验性多发性硬化症
  • 批准号:
    7394180
  • 财政年份:
    2007
  • 资助金额:
    $ 34.52万
  • 项目类别:

相似海外基金

Drought and Climate Resilience of Smallholders in Afghanistan: Needs and Preferences Analysis
阿富汗小农的干旱和气候抵御能力:需求和偏好分析
  • 批准号:
    24K16366
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
'Diaspora States' in Somalia and Afghanistan: New Perspectives on Post-War Politics, Dual Citizenship and International Statebuilding
索马里和阿富汗的“侨民国家”:战后政治、双重国籍和国际国家建设的新视角
  • 批准号:
    EP/X022048/1
  • 财政年份:
    2023
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Fellowship
Improving learning outcomes in Afghanistan and Pakistan in the midst of COVID-19 through Community based system dynamics and project-based learning
通过基于社区的系统动态和基于项目的学习,在 COVID-19 期间改善阿富汗和巴基斯坦的学习成果
  • 批准号:
    ES/X014088/1
  • 财政年份:
    2022
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Research Grant
On Politics and Justice: British Military Justice following War Crimes Allegations in Iraq and Afghanistan, 2001-present
论政治与司法:2001 年至今,伊拉克和阿富汗战争罪指控后的英国军事司法
  • 批准号:
    2745904
  • 财政年份:
    2022
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Studentship
U.S and Afghanistan - why the nation-building project failed?
美国和阿富汗——国家建设项目为何失败?
  • 批准号:
    22K01385
  • 财政年份:
    2022
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Market Economy and Conflict; Disjuncture between the Politics and Economics of Statebuilding in Afghanistan during 2001-2021
市场经济与冲突;
  • 批准号:
    ES/X006832/1
  • 财政年份:
    2022
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Fellowship
Analysis of the structure of conflict between ethnicities in the transformation of national integration policy in Afghanistan
阿富汗民族融合政策转型中的族群冲突结构分析
  • 批准号:
    19K20529
  • 财政年份:
    2019
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Neurosteroid Intervention for PTSD in Iraq/Afghanistan-era Veterans
神经类固醇干预伊拉克/阿富汗时期退伍军人的创伤后应激障碍
  • 批准号:
    10417141
  • 财政年份:
    2019
  • 资助金额:
    $ 34.52万
  • 项目类别:
Neurosteroid Intervention for PTSD in Iraq/Afghanistan-era Veterans
神经类固醇干预伊拉克/阿富汗时期退伍军人的创伤后应激障碍
  • 批准号:
    10589071
  • 财政年份:
    2019
  • 资助金额:
    $ 34.52万
  • 项目类别:
A pilot assessment of miltefosine's efficacy and tolerability for treating cutaneous Leishmania tropica in Afghanistan
在阿富汗对米替福辛治疗皮肤热带利什曼原虫的疗效和耐受性进行初步评估
  • 批准号:
    MR/R018391/1
  • 财政年份:
    2018
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了